Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20032972HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20054814HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20045051HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20025840HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20029414HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20014251HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20043299HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20043472HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20054644HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TVIS20037296HPVENSG00000171094.18protein_codingALKYesNo238B6D4Y2
Q9UM73
TCGA Plot Options
Drug Information
GeneALK
DrugBank IDDB08865
Drug NameCrizotinib
Target IDBE0000359
UniProt IDQ9UM73
Regulation Typeinhibitor
PubMed IDs22594847
CitationsForde PM, Rudin CM: Crizotinib in the treatment of non-small-cell lung cancer. Expert Opin Pharmacother. 2012 Jun;13(8):1195-201. doi: 10.1517/14656566.2012.688029.
GroupsApproved; Investigational
Direct ClassificationPyrazolylpyridines
SMILESC[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
Pathways
PharmGKBPA165946122
ChEMBLCHEMBL601719